DRMA
Dermata Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Dermata Therapeutics (DRMA) Stock: Buy, Sell, or Hold?
$0.72
+0.00 (+0.07%)
▲
5d:
-16.35%
30d:
-16.85%
90d:
-54.46%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$0.73 – $0.98
Position: OVERSOLD
Forward P/E & Valuation
-0.5x
Next 12M consensus est.
Wall Street Target
$4.00
+459.4% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.65 / $0.91
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: DRMA is down 16.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When DRMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: DRMA is currently trading at $0.71, which is considered oversold relative to its 30-day fair value range of $0.73 to $0.98.
Technical Outlook: Technically, DRMA is in a downtrend. Immediate support is located at $0.65, while resistance sits at $0.91.
Market Sentiment: DRMA scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+459.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DRMA is in a downtrend. Immediate support is located at $0.65, while resistance sits at $0.91.
Market Sentiment: DRMA scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+459.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.73 -
$0.98
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$0.73 -
$0.98
Current vs Trading Range
OVERSOLD
Support Level
$0.65
Resistance Level
$0.91
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (64/100)
- BULLISH: Trading 459.4% below Wall St target ($4.00)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.50
Wall Street Target
$4.00
(+459.4%)
Share DRMA Analysis
Share this live DRMA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DRMA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express bullish sentiment towards $DRMA, anticipating a potential move above $1. No recent news articles available.
Key Retail Themes:
Bullish price prediction
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 4:10 PM ET
Data refreshes hourly during market hours. Next update: 5:10 PM
Data refreshes hourly during market hours. Next update: 5:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DRMA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DRMA Research Pages
